INCREASE IN ANTI-5HT ACTIVITY BY 1-METHYLATION OF CLAVINE-TYPE ERGOT ALKALOIDS

被引:4
|
作者
YUI, T
TAKEO, Y
机构
来源
JAPANESE JOURNAL OF PHARMACOLOGY | 1964年 / 14卷 / 01期
关键词
D O I
10.1254/jjp.14.107
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:107 / &
相关论文
共 50 条
  • [1] BIOGENESIS OF CLAVINE-TYPE ERGOT ALKALOIDS
    TAYLOR, EH
    RAMSTAD, E
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1961, 50 (08) : 681 - &
  • [2] Ergot alkaloids in sclerotia collected in Japan: synthetic profiles and induction of apoptosis by Clavine-type compounds
    Yuji Doi
    Daigo Wakana
    Satoshi Kitaoka
    Fumiaki Sato
    Eiji Tanaka
    Hisashi Takeda
    Tomoo Hosoe
    Journal of Natural Medicines, 2023, 77 : 306 - 314
  • [3] Ergot alkaloids in sclerotia collected in Japan: synthetic profiles and induction of apoptosis by Clavine-type compounds
    Doi, Yuji
    Wakana, Daigo
    Kitaoka, Satoshi
    Sato, Fumiaki
    Tanaka, Eiji
    Takeda, Hisashi
    Hosoe, Tomoo
    JOURNAL OF NATURAL MEDICINES, 2023, 77 (02) : 306 - 314
  • [4] New routes to clavine-type ergot alkaloids.: Part 2:: Synthesis of the last, so far not yet synthesized member of the clavine alkaloid family, (±)-cycloclavine
    Incze, Maria
    Dornyei, Gabor
    Moldvai, Istvan
    Temesvari-Major, Eszter
    Egyed, Orsolya
    Szantay, Csaba
    TETRAHEDRON, 2008, 64 (13) : 2924 - 2929
  • [5] New routes to clavine-type ergot alkaloids.: Part 1.: First total synthesis of three natural products:: (+)setoclavine, (+)-isosetoclavine, (-)9,10-dihydroisosetoclavine, and structure correction of the latter
    Moldvai, I
    Temesvári-Major, E
    Gács-Baitz, E
    Incze, M
    Dörnyei, G
    Szántay, C
    HETEROCYCLES, 2006, 67 (01) : 291 - 298
  • [6] Comprehensive Comparison of the Ergot Alkaloids Family with 5-HT1A Receptor Pharmacophore Models
    Cejka, J.
    Kratochvil, B.
    Jegorov, A.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2000, 56 : S282 - S282
  • [7] A Short Synthesis of Ergot Alkaloids and Evaluation of the 5-HT1/2 Receptor Selectivity of Lysergols and Isolysergols
    Tasker, Nikhil R.
    Wipf, Peter
    ORGANIC LETTERS, 2022, 24 (40) : 7255 - 7259
  • [8] ACTIONS OF NONPEPTIDE ERGOT ALKALOIDS AT 5-HT1-LIKE AND 5-HT2 RECEPTORS MEDIATING VASCULAR SMOOTH-MUSCLE CONTRACTION
    MACLENNAN, SJ
    MARTIN, GR
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1990, 342 (02) : 120 - 129
  • [9] ERGOT ALKALOIDS REDUCE CRANIAL ARTERIOVENOUS SHUNTING IN PIGS - NO MAJOR ROLE FOR 5-HT1-LIKE RECEPTORS
    DENBOER, MO
    HELLIGERS, JPC
    FERRARI, MD
    SAXENA, PR
    CEPHALALGIA, 1991, 11 : 203 - 204
  • [10] Serotonin Receptor Activity Profiles (5-HT2B and 5-HT2A) for Nine Commercialized Ergot Alkaloids Correspond to Known Risks of Fibrosis and Hallucinations
    Alam, A.
    Alam, A.
    HEADACHE, 2019, 59 : 135 - 136